The antitumor mechanism of immuno-flap treatment in a rat model of head and neck cancer
These results indicate that immuno-flap transfer to prevent local recurrence in patients with HNC has potential for clinical application given the improved yield and quality of antitumor DCs.
Authors
- Chie Maeda
- Akira Iizuka (ORCID: https://orcid.org/0000-0002-2545-5138)
- Jun Araki
- Yoshichika Yasunaga (ORCID: https://orcid.org/0000-0002-4858-6739)
- Tadashi Ashizawa
- Akari Kanematsu
- Yasuto Akiyama (ORCID: https://orcid.org/0000-0003-3813-7726)
- Tomoatsu Ikeya
- Hiroaki Mori (ORCID: https://orcid.org/0009-0002-1785-0944)
- Haruo Miyata
- Kazue Yamashita
Institutions
- Keio University (JP)
- Shizuoka Cancer Center (JP)
Publication Details
- Journal
- Cancer Immunology Immunotherapy
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1007/s00262-025-04208-8
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Keio University
- Japan Society for the Promotion of Science